Statement From Sarepta Therapeutics on Stock Volatility

[at noodls] – CAMBRIDGE, MA — (MARKETWIRE) — 01/30/13 — Sarepta Therapeutics (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, today issued the following statement from Chris Garabedian, President … more

View todays social media effects on SRPT

View the latest stocks trending across Twitter. Click to view dashboard

See who Sarepta is hiring next, click here to view